EnteroMedics

homesitemapcontact us

   search

 

   
 
 
   
   
 

Overview

 
 

About vBloc® Therapy

 
 

vBloc® Maestro® System

 
 

Obesity

 
 

Clinical Experience

 

     Obesity

 
 

     Diabetes

 
 

     Cardiovascular Disease

 
 

Publications

 

 

 

 

EnteroMedics® has significant experience with VBLOC® vagal blocking therapy; more than 600 patients have been implanted with the Maestro® System to date, some out to five years. Clinical evidence from multiple trials supports the safety, efficacy and sustainability of weight loss through vBloc® Therapy. In addition, vBloc® Therapy early data suggest effects on obesity-related co-morbidities, including diabetes and hypertension. All vBloc® Therapy studies to date have met their safety goals, including no therapy-related serious adverse events reported across the entire study population.

Learn more about our clinical experience in:
Obesity
Diabetes
Cardiovascular Disease